These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3663815)

  • 21. Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
    Yin G; Li Y; Ji Y
    Biometrics; 2006 Sep; 62(3):777-84. PubMed ID: 16984320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local influence diagnostics for quasi-likelihood and lognormal estimates of a biological reference point from some fish stock and recruitment models.
    Cadigan NG
    Biometrics; 2006 Sep; 62(3):713-20. PubMed ID: 16984312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A shared response model for clustered binary data in developmental toxicity studies.
    Pang Z; Kuk AY
    Biometrics; 2005 Dec; 61(4):1076-84. PubMed ID: 16401281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A measure of tumorigenic potency incorporating dose-response shape.
    Meier KL; Bailer AJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.
    Goldoni M; Johansson C
    Toxicol In Vitro; 2007 Aug; 21(5):759-69. PubMed ID: 17420112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicology databases and the concept of thresholds of toxicological concern as used by the JECFA for the safety evaluation of flavouring agents.
    Renwick AG
    Toxicol Lett; 2004 Apr; 149(1-3):223-34. PubMed ID: 15093268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global tests for multiple binary outcomes.
    Lefkopoulou M; Ryan L
    Biometrics; 1993 Dec; 49(4):975-88. PubMed ID: 8117908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient design for estimation of median lethal dose and quantal dose-response curves.
    Kalish LA
    Biometrics; 1990 Sep; 46(3):737-48. PubMed ID: 2242412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothesis testing and the choice of the dose-response model.
    Oughton D
    Toxicol Lett; 2006 Mar; 162(1):98-110. PubMed ID: 16325358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress biology and hormesis: the Yerkes-Dodson law in psychology--a special case of the hormesis dose response.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(5):453-62. PubMed ID: 18568865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of litter effects on dose-response modeling in teratology.
    Kupper LL; Portier C; Hogan MD; Yamamoto E
    Biometrics; 1986 Mar; 42(1):85-98. PubMed ID: 3719065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new threshold dose-response model including random effects for data from developmental toxicity studies.
    Hunt DL; Rai SN
    J Appl Toxicol; 2005; 25(5):435-9. PubMed ID: 16092077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling overdispersion in toxicological mortality data grouped over time.
    Hines RJ; Lawless JF
    Biometrics; 1993 Mar; 49(1):107-21. PubMed ID: 8513096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicology experimental design and conduct as measured by interlaboratory collaborative studies.
    Weil CS
    J Assoc Off Anal Chem; 1975 Jul; 58(4):683-8. PubMed ID: 1150606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A parametric model for detecting hormetic effects in developmental toxicity studies.
    Hunt DL; Bowman D
    Risk Anal; 2004 Feb; 24(1):65-72. PubMed ID: 15028001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methodological questions in assessing the body's reaction to the action of chemical substances].
    Kopeĭka IG
    Vrach Delo; 1988 Aug; (8):101-4. PubMed ID: 3206867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.